
Popular weight-loss drugs linked to sudden vision loss, research suggests
Fox News
New research links weight-loss medications semaglutide and tirzepatide, including Ozempic, Wegovy and Mounjaro, to an increased risk of rare eye conditions.
Angelica Stabile is a lifestyle reporter for Fox News Digital.
One study found a modest risk of developing non-arteritic anterior ischaemic optic neuropathy (NAOIN) – a rare eye condition that can lead to sudden vision loss due to lack of blood flow – in association with semaglutide and tirzepatide.
More Related News













